These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. beta 1-selective adrenoceptor antagonists. 1. Synthesis and beta-adrenergic blocking activity of a series of binary (aryloxy)propanolamines. Kierstead RW; Faraone A; Mennona F; Mullin J; Guthrie RW; Crowley H; Simko B; Blaber LC J Med Chem; 1983 Nov; 26(11):1561-9. PubMed ID: 6138434 [TBL] [Abstract][Full Text] [Related]
16. Potent, selective benzenesulfonamide agonists of the human beta 3 adrenergic receptor. Weber AE; Mathvink RJ; Perkins L; Hutchins JE; Candelore MR; Tota L; Strader CD; Wyvratt MJ; Fisher MH Bioorg Med Chem Lett; 1998 May; 8(9):1101-6. PubMed ID: 9871716 [TBL] [Abstract][Full Text] [Related]
17. Cardioselectivity as a function of molecular structure in beta-adrenoceptor blocking agents of the 1-(para-substituted aryloxy)-3-(isopropylamino)propan-2-ol type. Erez M; Shtacher G; Weinstock M J Med Chem; 1978 Sep; 21(9):982-4. PubMed ID: 31488 [TBL] [Abstract][Full Text] [Related]
19. Characterization of beta-adrenoceptor subtypes in the ferret urinary bladder in vitro and in vivo. Takeda H; Igawa Y; Komatsu Y; Yamazaki Y; Akahane M; Nishizawa O; Ajisawa Y Eur J Pharmacol; 2000 Sep; 403(1-2):147-55. PubMed ID: 10969156 [TBL] [Abstract][Full Text] [Related]
20. Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol. Brodde OE; Daul A; Michel-Reher M; Boomsma F; Man in 't Veld AJ; Schlieper P; Michel MC Circulation; 1990 Mar; 81(3):914-21. PubMed ID: 1968366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]